DEANA MCREYNOLDS: Open Payments
NPI 1386879377 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 16 payments from 9 companies in 2025. Trend: 2023 $148 · 2024 $355 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $91 |
| Axsome Therapeutics, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Corium, LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
Products named: COBENFY, Auvelity, INGREZZA, TRINTELLIX, Azstarys, REXULTI, VRAYLAR, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
